FDA Approves First Generic Capecitabine to Treat Colorectal and Breast Cancers
The US Food and Drug Administration today approved the first generic version of Xeloda (capecitabine), an oral chemotherapy pill used to treat cancer of the colon or rectum (colorectal cancer) that has spread to other parts of the body (metastatic), and metastatic breast cancer.
Stopping Cancer: It's Not a Pain in the Butt
March is National Colorectal Cancer Awareness Month. In observance of the month, the American Cancer Society and other health-promoting organizations are disseminating information about the highly preventable disease.